ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $125K of Ardelyx, Inc.
Sold$125,104
$7.00Price
17,872Shares
−3%Stake
What ARDX did after the filing
- The stock from Thu, Jun 6 open, $7.08
- −19.5%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jul 22 close.
Traded Mon, Jun 3. Filed Wed, Jun 5, 4:00 PM ET, after the close. Returns use the Jun 6 open and the Jul 22 close. Not investment advice.